Edition:
United States

Athersys Inc (ATHX.OQ)

ATHX.OQ on NASDAQ Stock Exchange Capital Market

2.38USD
18 Sep 2017
Change (% chg)

-- (--)
Prev Close
$2.38
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
151,347
52-wk High
$2.44
52-wk Low
$1.02

Chart for

About

Athersys, Inc. is an international biotechnology company that is focused primarily in the field of regenerative medicine. The Company's MultiStem cell therapy, an allogeneic stem cell product, is its lead platform product and is in later-stage clinical development. Its clinical development programs are focused on treating... (more)

Overall

Beta: -0.17
Market Cap(Mil.): $271.11
Shares Outstanding(Mil.): 113.91
Dividend: --
Yield (%): --

Financials

  Industry Sector
P/E (TTM): -- 79.97 16.21
EPS (TTM): -- -- --
ROI: -- 3.01 14.56
ROE: -- 4.79 13.83

BRIEF-Athersys Q2 loss per share $0.06

* Q2 earnings per share view $-0.07 -- Thomson Reuters I/B/E/S Source text for Eikon: Further company coverage:

Aug 09 2017

BRIEF-Athersys reports alignment of key regulators for pivotal registration study in stroke

* Athersys reports alignment of key regulators for pivotal registration study in stroke

Aug 07 2017

BRIEF-Athersys reports Q1 loss per share $0.06

* Q1 earnings per share view $-0.07 -- Thomson Reuters I/B/E/S Source text for Eikon: Further company coverage:

May 09 2017

Earnings vs. Estimates